Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2014
10/02/2014WO2014157569A1 Heterocyclic compound
10/02/2014WO2014157540A1 Anti-inflammatory agent
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014WO2014155135A1 Methods for the treatment of autoimmune diseases
10/02/2014WO2014154930A1 Anti-factor b antibody, pharmaceutical composition that can be used for the treatment of diseases of the complement system, and uses thereof
10/02/2014WO2014154843A1 Modified tgf-beta2 oligonucleotides
10/02/2014WO2014153685A1 Chinese medicine capsule for treating lupus erythematosus
10/02/2014WO2014153674A1 Influenza virus-like particle production in plants
10/02/2014US20140294857 Methods of obtaining a specific binding member that binds eotaxin
10/02/2014US20140294842 Assays, Methods and Means
10/01/2014EP2783701A2 Extended treatment of multiple sclerosis
10/01/2014EP2782602A1 Method for prevention of colectomy
10/01/2014EP2782570A1 Heterocyclic inhibitors of glutaminase
09/2014
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846026 Composition comprising immunogenic microparticles
09/30/2014CA2624925C Immunomodulation using placental stem cells
09/30/2014CA2606102C Modulation of antibody effector function by hinge domain engineering
09/30/2014CA2590935C Fc.gamma.riib-specific antibodies and methods of use thereof
09/25/2014WO2014153363A1 Method for generation of broadly neutralizing anti-pathogen antibodies
09/25/2014WO2014153226A1 Arginine methyltransferase inhibitors and uses thereof
09/25/2014WO2014153172A1 Pyrazole derivatives as prmt1 inhibitors and uses thereof
09/25/2014WO2014153090A1 Pyrazole derivatives asprmt1 inhibitors and uses thereof
09/25/2014WO2014152604A1 P2x7 modulators
09/25/2014WO2014152444A1 Histone deacetylase inhibitors
09/25/2014WO2014151919A1 Factor h for transplantation
09/25/2014WO2014151620A1 5-thiazolecarboxamide dervatives and their use as btk inhibitors
09/25/2014WO2014151386A1 Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
09/25/2014WO2014151380A1 1,2,6-substituted benzimidazoles as flap modulators
09/25/2014WO2014151367A1 1,2,5-substituted benzimidazoles as flap modulators
09/25/2014WO2014150566A1 Reducing the risk of autoimmune disease
09/25/2014WO2014148638A1 Aptamer to il-17 and use thereof
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014148489A1 Cyclic peptide
09/25/2014WO2014148422A1 Licorice hydrolysis extraction composition
09/25/2014WO2014148136A1 Compound having anti-allergic activity and use of same
09/25/2014WO2014147526A1 Tofacitinib oral sustained release dosage forms
09/25/2014WO2014147178A1 Hdac6 inhibitors and uses thereof
09/25/2014WO2014147095A1 Lipohillic oligonucleotide analogs
09/25/2014WO2014146575A1 Antibodies and methods for treating estrogen receptor-associated diseases
09/25/2014WO2014146493A1 Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/25/2014WO2014146491A1 Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/25/2014WO2014146490A1 Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140288034 Compound capable of binding s1p receptor and pharmaceutical use thereof
09/25/2014US20140286949 Method of attenuating reactions to skin irritants
09/24/2014EP2781523A1 Lipophilic oligonucleotide analogs
09/24/2014EP2781517A1 Nitrogenated heterocyclic compound
09/24/2014EP2781508A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists
09/24/2014EP2781216A1 Chemokine receptor activity regulator
09/24/2014EP2780375A1 Binding molecules for bcma and cd3
09/24/2014EP2780374A1 Binding molecules for bcma and cd3
09/24/2014EP2780351A1 Clostridium difficile lipoteichoic acid and uses thereof
09/24/2014EP2780350A2 Synthetic derivatives of mpl and uses thereof
09/24/2014EP2780336A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain
09/23/2014US8841433 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/23/2014US8841307 Method of using diketopiperazines and composition containing them
09/23/2014US8841261 Functional powdery product
09/23/2014US8841254 Method for treatment of anxiety
09/23/2014US8840934 Uses of ammonium chloride
09/23/2014CA2608153C Thiazole derivatives for use as p13k modulators
09/23/2014CA2548990C Toll-like receptor 4 (tlr4)-neutralizing antibodies
09/23/2014CA2500935C Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
09/18/2014WO2014146097A1 Compositions for treatment and/or prevention of autoimmune disorders
09/18/2014WO2014145907A1 Targeting t cells with heterodimeric proteins
09/18/2014WO2014145749A1 Targeted polymeric inflammation-resolving nanoparticles
09/18/2014WO2014144659A1 Pyrazole derivatives as prmt1 inhibitors and uses thereof
09/18/2014WO2014144623A1 Isolation of factor h from fraction i paste
09/18/2014WO2014142933A1 Neuroimmunological response to stress
09/18/2014WO2014142705A1 A cytokine-containing drug having an antiviral, antimicrobial, immunomodulatory and anti-inflammatory effect for treating and prophylaxis of infectious diseases
09/18/2014WO2014142653A1 Vaccination composition
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014142084A1 METHOD FOR PRODUCING MONOCLONAL IgA ANTIBODY
09/18/2014WO2014141171A1 Pyridin-4-yl derivatives
09/18/2014WO2014141127A1 Composition containing buffered aminoalkyl glucosaminide phosphate derivatives and its use for enhancing an immune response
09/18/2014WO2014141111A1 Methods for prevention and treatment of graft-versus-host disease
09/18/2014WO2014140592A1 Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as ssao inhibitors
09/18/2014WO2014140313A1 Macrocyclic salt-inducible kinase inhibitors
09/18/2014WO2014140091A1 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140081A1 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140078A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140075A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014139882A1 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
09/18/2014WO2014139458A1 Fused ring compound containing pyrimidine or pyridine and use thereof as anti-tumour drug
09/18/2014WO2014139425A1 Anti-blys monoclonal antibody and pharmaceutical composition containing antibody
09/18/2014WO2014138979A1 Pyrazole derivatives and their uses thereof
09/18/2014WO2014138924A1 Compositions and methods for treating clostridium difficile-associated diseases
09/18/2014WO2014138862A1 Human monoclonal antibodies that neutralize bioactivity of granulocyte macrophage colony-stimulating factor and methods and uses thereof
09/18/2014WO2014138824A1 Immune modulation
09/18/2014WO2014138819A1 Agents that neutralize il-3 signaling and uses thereof
09/18/2014WO2014138805A1 Anti il-3r alpha agents and uses thereof
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140275225 Modulators of pharmacological agents
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/17/2014EP2778175A1 Humanized anti-interleukin 3 receptor alpha chain antibodies for use in treating acute myeloid leukemia (AML)
09/17/2014EP2778156A1 Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
09/17/2014EP2777712A1 Adjuvants for polysaccharide vaccines and resulting formulations
09/17/2014EP2776567A2 Compositions and methods for treatment of cytomegalovirus
09/17/2014EP2776445A1 Therapeutically active thiazolo-pyrimidine derivatives
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 1172